# Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds

> **NCT03319719** · NA · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Correction of Moderate to Severe Nasolabial Folds

## Interventions

- **DEVICE:** Belotero® Balance with integral lidocaine
- **DEVICE:** Belotero® Balance

## Key facts

- **NCT ID:** NCT03319719
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2017-12-06
- **Final completion:** 2017-12-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319719, "Evaluation of Pain With Belotero® Balance With Integral Lidocaine for Correction of the Nasolabial Folds". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03319719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*